Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe most serious side effects of Wegovy are acute pancreatitis, gallbladder problems, and severe dehydration from persistent vomiting or diarrhoea. These are uncommon but require urgent medical attention. The most frequent side effects are gastrointestinal — nausea, vomiting, constipation, diarrhoea — and most people experience them mildly, if at all, and they typically ease within days to a couple of weeks. Wegovy (semaglutide) is a prescription-only medicine, and a clinical assessment before you start it exists precisely so a prescriber can weigh these risks against your individual health picture.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A small number of side effects can become genuinely dangerous, and knowing the signals matters more than any list. The clearest one to understand is pancreatitis. In January 2026 the MHRA's Drug Safety Update on GLP-1 medicines drew attention to acute pancreatitis as an infrequent but potentially serious complication. The symptom to act on is severe, persistent stomach pain that spreads to the back, with or without vomiting. If that happens, stop eating and drinking and go to A&E or call 999; do not wait for it to pass on its own.
Gallbladder problems, including gallstones and gallbladder inflammation, are also documented. The warning signs are sharp pain in the upper right abdomen, sometimes with fever or yellowing of the skin. Again, these need prompt assessment.
Severe dehydration is a third category worth taking seriously. It's not caused by the medicine directly, but by prolonged vomiting or diarrhoea. Signs include dizziness when you stand, very dark urine, and a dry mouth that won't ease. If you can't keep fluids down for more than a day, seek medical advice rather than trying to push through. If you want a thorough overview before or during treatment, our page covering what are the side effects of Wegovy covers the complete picture of what to watch for across the whole treatment period.
The commonest experience (the one our prescribers hear about most) is nausea, particularly in the first days after starting or moving up a dose. Constipation, loose stools, reflux, burping, and general stomach discomfort all appear in the trial data. Fatigue and mild headaches also show up, especially early on.
These effects are genuinely unpleasant for some people but are not medically dangerous in themselves. They tend to be worst when your body is adjusting to a new dose level, then gradually settle. A practical habit that helps many people: before you go to bed each night in the first two weeks of a new dose, run a quick mental check, how much did you drink today, and did you eat something small and bland with each meal? Hydration and small portions are the two levers you actually control, and consciously tracking them takes less than a minute.
The common side effects of Wegovy page goes into more detail on managing these day-to-day symptoms, and the NHS semaglutide page lists them alongside practical self-care steps.
Yes. Allergic reactions (rash, swelling of the face or throat, difficulty breathing) are uncommon but a reason to stop the medicine immediately and call 999. Thoughts of self-harm or low mood have been reported; the exact relationship to the medicine is still being studied, but if your mental state changes after starting Wegovy, tell your prescriber.
For people with diabetic eye disease, semaglutide has in some cases been linked to worsening of diabetic retinopathy, particularly early in treatment. This is mainly relevant in the diabetes context rather than weight management, but anyone with pre-existing eye disease should flag it at consultation.
Pulse rate increases by a few beats per minute on average, usually not significant, but worth monitoring if you have an underlying heart condition. The main side effects of Wegovy page addresses the full spectrum including these less-discussed effects. If any side effect concerns you, you can report it directly using the MHRA Yellow Card scheme, it's open to patients as well as healthcare professionals.
The worst of the gastrointestinal side effects typically cluster around dose changes. Wegovy is titrated gradually (starting low and increasing every four weeks or so) and each step up can briefly revive symptoms you thought you'd already moved past. This is normal. It doesn't mean the medicine has stopped working; it means your body is re-adjusting.
By the time most people are on the maintenance dose, GI symptoms have reduced considerably for the majority. What sometimes replaces them are subtler things: changes in food preferences, a reduced interest in alcohol (reported anecdotally and in some studies), and for some, increased fatigue if dietary intake has dropped significantly. Our page on what side effects to expect from semaglutide explores how these patterns compare across people using the medicine for different purposes.
People who stop Wegovy abruptly sometimes experience rapid return of appetite. This isn't a side effect in the medical sense, but it's worth understanding before you decide to pause. If you're thinking about what comes next after treatment, the Wegovy overview covers the longer-term picture. And if you'd like to understand how semaglutide side effects change across the weeks and months, that page breaks down the timeline in detail. Our prescribers discuss all of this as part of the free consultation (including which side effects are most relevant to your own health history) if you'd like to check your eligibility.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.